Nurse Practitioner, Family · Scottsbluff, NE
NPI
1891204624
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4021 Avenue B
Scottsbluff, NE, 69361
Phone (308) 630-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
1,513 services
Medicare patients, 2024
200
Average age 71
Drug cost, 2024
$2.0M
3,568 prescriptions
Company payments, 2025
$87.1
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura E Perry was code 99214 (office e&m - established), 503 times for 176 patients. In total Laura E Perry billed 1,513 services in 13 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 503 | 176 | $72.05 | $36K |
| 83036 Blood Count | Office | 386 | 166 | $9.52 | $3,675 |
| 95251 Test - Miscellaneous | Office | 352 | 122 | $20.13 | $7,086 |
| 99215 Office E&M - Established | Office | 64 | 43 | $98.15 | $6,281 |
| 99211 Office E&M - Established | Office | 57 | 39 | $12.05 | $687 |
| 99205 Office E&M - New | Office | 17 | 17 | $93.41 | $1,588 |
By year: 2022 $53K for 1,083 services; 2023 $72K for 1,812 services; 2024 $58K for 1,513 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 386 | 166 | $9.52 | $3,675 |
Medicare prescription drug claims, 2024
In 2024, the drug Laura E Perry prescribed most often to Medicare patients was Ozempic (Semaglutide), with 552 prescriptions and refills. In total Laura E Perry wrote 3,568 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 552 | 606 | 75 | $548K |
| Jardiance Empagliflozin | 459 | 695 | 86 | $368K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 322 | 403 | 75 | $408K |
| Tresiba Flextouch U-100 Insulin Degludec | 193 | 432 | 64 | $101K |
| Farxiga Dapagliflozin Propanediol | 174 | 196 | 27 | $96K |
| Novolog Flexpen Insulin Aspart | 148 | 191 | 59 | $21K |
| Metformin Hcl Er Metformin Hcl | 139 | 367 | 49 | $1,676 |
| Januvia Sitagliptin Phosphate | 134 | 176 | 30 | $92K |
| Pioglitazone Hcl Generic | 121 | 253 | 35 | $1,930 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 118 | 282 | 57 | $14K |
| Levothyroxine Sodium Generic | 112 | 304 | 34 | $1,073 |
| Atorvastatin Calcium Generic | 108 | 282 | 35 | $1,291 |
| Rybelsus Semaglutide | 62 | 62 | 15 | $57K |
| Mounjaro Tirzepatide | 56 | 58 | 13 | $57K |
| Humalog Kwikpen U-100 Insulin Lispro | 55 | 78 | 20 | $9,206 |
Brand drugs: 2,614 claims; generic drugs: 728 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura E Perry $87.1 ($87.1 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novo Nordisk Inc with $49.55.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.